The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
基本信息
- 批准号:10612424
- 负责人:
- 金额:$ 51.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-14 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAddressAfferent NeuronsAirAllergensAllergicAllergic rhinitisAntihistaminesAttenuatedAxonBasic ScienceBehaviorBehavioralBrain StemBurning PainCalciumCapsaicinCell DegranulationCellsChemicalsChili PepperChronicClinicalClinical ResearchCommon CoreDefense MechanismsDetectionDevelopmentEnvironmental IrritantsEsthesiaFiberG-Protein-Coupled ReceptorsGeneticHistamineHumanHypersensitivityIgEImaging DeviceImmuneImmunologicsInfectionIrritantsLabelLightLungMediatingMediatorModelingMucous MembraneMusNeuroimmuneNeuronsNosePathologicPatternPhysiologicalPilot ProjectsPlayPopulationProductivityPropertyPruritusQuality of lifeReflex actionRespirationRoleSensorySignal TransductionSneezingStimulusStructure of mucous membrane of noseStructure of trigeminal ganglionSymptomsTestingTherapeuticWild Type Mouseaerosolizedcholinergicdesigner receptors exclusively activated by designer drugsfiber cellgenetic approachimaging approachinsightmast cellnerve supplyneuromechanismneuropeptide FFneurotransmissionnew therapeutic targetnovelnovel therapeuticspathogenpharmacologicpreventresponsesensory stimulussymptomatology
项目摘要
Abstract
Allergic rhinitis is the most common mucosal allergy. Its cardinal symptoms include excessive sneezing
and rhinorrhea, which severely impact our life quality and productivity. Although antihistamines effectively
relieved sneezing induced by intermittent mild allergic rhinitis, they are ineffective against persistent
moderate/severe allergic rhinitis. The development of new drugs for alleviating allergic sneezing is hindered by
a lack of information about the principal nasal sensory neurons that mediate sneezing and their interactions with
immune cells. In this proposal, we hypothesize that a highly restricted population of nasal sensory neurons
defined by the expression of MrgprC11 detect mast cell mediators in allergic rhinitis and trigger the sneezing
reflex. In Aim 1, we will characterize the innervation pattern of MrgprC11-expressing fibers in the nasal mucosa
and examine their pathological changes under allergic rhinitis using genetic labeling and axonal tracing
approaches. Furthermore, we will determine their physiological responses to a variety of sneeze-inducing
molecules using a novel ex vivo calcium-imaging tool. These studies will provide important information on the
initial detection of nasal irritants and transduction of sneezing signals. In Aim 2, we will define the role of
MrgprC11+ fibers in acute sneezing. We will determine whether ablation of MrgprC11+ neurons attenuates
sneezing responses to a variety of nasal irritants and whether selective activation of MrgprC11+ sensory fibers
in the nasal mucosa evokes sneezing. These studies will establish whether MrgprC11+ sensory fibers are
required for sneezing induced by different sensory stimuli. In Aim 3, we will investigate the neuro-immune
interactions between MrgprC11+ nasal sensory fibers and mast cells in allergic rhinitis. We will test whether
degranulated mast cells activate MrgprC11+ nasal sensory fibers to induce sneezing in allergic rhinitis.
Furthermore, we will determine whether pharmacological silencing of MrgprC11+ sensory fibers is a feasible
therapeutic strategy to control sneezing associated with allergic rhinitis. These studies will not only advance our
understanding of the neuro-immune interactions that trigger sneezing, but also provide a novel neuronal target
for controlling nasal allergic symptoms.
摘要
过敏性鼻炎是最常见的粘膜过敏。其主要症状包括打喷嚏过多
和腹泻,严重影响我们的生活质量和生产力。虽然抗组胺药有效地
缓解间歇性轻度过敏性鼻炎引起的打喷嚏,对持续性过敏性鼻炎无效。
中度/重度过敏性鼻炎。缓解过敏性喷嚏的新药的开发受到以下因素的阻碍:
缺乏关于调节打喷嚏的主要鼻感觉神经元及其与
免疫细胞在这个提议中,我们假设一个高度有限的鼻感觉神经元群体,
通过MrgprC 11的表达来定义检测肥大细胞介质在变应性鼻炎中的作用并触发打喷嚏
反射。在目的1中,我们将描述鼻粘膜中MrgprC 11表达纤维的神经支配模式
应用基因标记和轴突追踪技术检测变应性鼻炎时的病理变化
接近。此外,我们还将确定他们对各种诱发喷嚏的生理反应。
分子使用一种新的离体钙成像工具。这些研究将提供重要信息,
鼻刺激物的初始检测和打喷嚏信号的转导。在目标2中,我们将定义
急性打喷嚏中的MrgprC 11+纤维我们将确定MrgprC 11+神经元的消融是否减弱了
对各种鼻刺激物的打喷嚏反应以及MrgprC 11+感觉纤维是否选择性激活
会引起打喷嚏这些研究将确定MrgprC 11+感觉纤维是否
所需的不同感官刺激诱发打喷嚏。在目标3中,我们将研究神经免疫
变应性鼻炎中MrgprC 11+鼻感觉纤维和肥大细胞之间的相互作用我们将测试
脱颗粒肥大细胞激活MrgprC 11+鼻感觉纤维以诱导变应性鼻炎中的打喷嚏。
此外,我们将确定是否药理学沉默MrgprC 11+感觉纤维是一个可行的,
控制与过敏性鼻炎相关的打喷嚏的治疗策略。这些研究不仅将促进我们的
了解引发打喷嚏的神经免疫相互作用,但也提供了一个新的神经靶点
控制鼻过敏症状
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qin Liu其他文献
Qin Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qin Liu', 18)}}的其他基金
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
- 批准号:
10626831 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
CRISPR/Cas9-based gene editing approaches for the treatment of USH2A-associated diseases
基于 CRISPR/Cas9 的基因编辑方法用于治疗 USH2A 相关疾病
- 批准号:
10446571 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
- 批准号:
10405559 - 财政年份:2021
- 资助金额:
$ 51.71万 - 项目类别:
The Neural Mechanism of Respiratory Allergies and Infections
呼吸道过敏和感染的神经机制
- 批准号:
10279722 - 财政年份:2021
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9160145 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
- 批准号:
9904543 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9908041 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
整合外周血生物标志物特征用于肺癌的诊断、预后、缓解和复发
- 批准号:
10376913 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
HISTAMINE-INDEPENDENT MAST CELL NERVE INTERACTIONS IN ALLERGY
过敏中不依赖组胺的肥大细胞神经相互作用
- 批准号:
9272358 - 财政年份:2016
- 资助金额:
$ 51.71万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 51.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 51.71万 - 项目类别:
Standard Grant